New City, NY, United States of America

Michael Rosconi

USPTO Granted Patents = 8 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Invention and Innovation: The Contributions of Michael Rosconi

Introduction

Michael Rosconi, an innovative inventor based in New City, NY, has made significant strides in the field of biotechnology through his groundbreaking patents. With a remarkable total of five patents to his name, Rosconi's work focuses on antigen binding molecules, specifically related to cancer treatment.

Latest Patents

Michael Rosconi's latest patents revolve around antigen binding molecule formats. These include:

- Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations.

- ABM conjugates that integrate the ABMs with cytotoxic or cytostatic agents.

- Pharmaceutical compositions that utilize the ABMs and ABM conjugates.

- Methods for employing the ABMs, ABM conjugates, and pharmaceutical compositions for cancer treatment.

- Nucleic acids encoding the ABMs and cells engineered to express the ABMs.

- Techniques for producing ABMs.

These innovations are poised to enhance therapeutic applications and develop new methodologies for combating cancer effectively.

Career Highlights

Michael Rosconi is a key inventor at Regeneron Pharmaceuticals, Inc., a prominent player in the biotech industry. His work contributes to the company's mission of advancing science to create life-saving therapies. Throughout his career, Rosconi has focused on the intersection of engineering and biology, showcasing his commitment to pushing the boundaries of medical science.

Collaborations

In his role at Regeneron Pharmaceuticals, Michael has collaborated with talented professionals such as Erica Pyles and Nina Liu. These collaborative efforts amplify the potential for innovation, enabling vital advancements in the field of biotechnology and therapeutics.

Conclusion

Michael Rosconi's contributions to patent innovations, particularly in cancer treatment, underscore the importance of research and collaboration in the biotechnology sector. As he continues to develop new pharmaceutical compositions and methods, his work will undoubtedly pave the way for future breakthroughs in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…